The Washington Times

Topic - American Society Of Clinical Oncology

Subscribe to this topic via RSS or ATOM
Related Stories
  • Study questions kidney cancer treatment in elderly

    In a stunning example of when treatment might be worse than the disease, a large review of Medicare records finds that older people with small kidney tumors were much less likely to die over the next five years if doctors monitored them instead of operating right away.

  • Study ties drug shortage to poorer cancer survival

    Young cancer patients who couldn't get a key medicine because of a national drug shortage were more likely to suffer a relapse than others who were able to get the preferred treatment, doctors report. It's the first evidence that a long-standing drug-supply problem probably has affected cancer treatment results in specific patients.

  • More prostate cancer test advice _ for some men

    There's more advice on the contentious issue of prostate cancer screening: A leading group of cancer specialists says the decision hinges in part on a man's life expectancy.

  • Study: Childhood cancer survivors face new risks

    Women treated with chest radiation for cancer when they were girls have a higher risk of developing breast cancer than previously thought, doctors warn.

  • More advanced therapies are being aimed at cancer

    New research shows a sharp escalation in the weapons race against cancer, with several high-tech approaches long dreamed of but not possible or successful until now.

  • Lung cancer CT scans: Just for older heavy smokers

    New lung cancer screening guidelines from three medical groups recommend annual scans but only for an older group of current or former heavy smokers.

  • A doctor works with a patient in a CT scanner at Southern New Hampshire Medical Center in Nashua, N.H. New lung-cancer screening guidelines recommend annual scans but only for an older group of current or former heavy smokers. The guidelines were published online Sunday in the Journal of the American Medical Association. (Associated Press)

    Lung-cancer scans advised for older heavy smokers

    New lung-cancer screening guidelines from three medical groups recommend annual scans but only for an older group of current or former heavy smokers.

  • Medical tests and treatments you should question

    Nine medical societies have released a list of 45 tests and treatments that patients should question and doctors should avoid in most cases as part of an effort to cut wasteful spending. Here is a sample:

  • Cancer's growing burden: the high cost of care

    Patti Tyree was afraid that cancer would steal her future. Instead, the cost of treating it has.

  • Study questions proton therapy for prostate cancer

    A warning to men considering a pricey new treatment for prostate cancer called proton therapy: Research suggests it might have more side effects than traditional radiation does.

  • New global killers: heart, lung disease and cancer

    What's killing us? For decades, global health leaders have focused on diseases that can spread _ AIDS, tuberculosis, new flu bugs. They pushed for vaccines, better treatments and other ways to control germs that were only a plane ride away from seeding outbreaks anywhere in the world.

  • New global killers: heart, lung disease and cancer

    What's killing us? For decades, global health leaders have focused on diseases that can spread — AIDS, tuberculosis, new flu bugs. Now they are turning to a new set of culprits causing what United Nations Secretary-General Ban Ki-moon calls "a public health emergency in slow motion." This time, germs aren't the target: We are, along with our bad habits like smoking, overeating and too little exercise.

  • Bristol-Myers pitches its cancer medicine pipeline

    Bristol-Myers Squibb Co. executives said Monday they have more than a half-dozen drugs in testing against different cancers and could get important data on them and possibly a couple of approvals this year.

  • Studies find new drugs boost skin cancer survival

    They're not cures, but two novel drugs produced unprecedented gains in survival in separate studies of people with melanoma, the deadliest form of skin cancer, doctors reported Sunday.

  • Hormone-blocking drug reduces breast cancer risk

    Millions of women at higher-than-usual risk of breast cancer have a new option for preventing the disease. Pfizer Inc.'s Aromasin cut the risk of developing breast cancer by more than half, without the side effects that have curbed enthusiasm for other prevention drugs, a major study found.

More Stories →

Happening Now